Vor Biopharma's CEO On Genome Engineering Of Hematopoietic Stem Cells
Source: Cell & Gene
![21_06_CGPodcast_1200x628_Ep13 21_06_CGPodcast_1200x628_Ep13](https://vertassets.blob.core.windows.net/image/b18bb616/b18bb616-aa9f-430f-ad02-d4caff97a416/375_250-21_06_cgpodcast_1200x628_ep13.png)
Vor Biopharma's CEO Dr. Robert Ang explains the company's lead engineered hematopoietic cell (eHSC) product candidate, genome engineering of HSCs, and the cell manufacturing process needed to leverage genome engineering technologies for the cells they're creating.
This website uses cookies to ensure you get the best experience on our website. Learn more